Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.000
+0.020 (2.03%)
At close: Nov 20, 2024, 4:00 PM
0.970
-0.030 (-3.00%)
Pre-market: Nov 21, 2024, 8:56 AM EST
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,525,333
Market Cap
98.26M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
MultiPlan | 2,800 |
Inovio Pharmaceuticals | 122 |
Fractyl Health | 102 |
Leap Therapeutics | 54 |
INmune Bio | 17 |
Monopar Therapeutics | 10 |
Anixa Biosciences | 5 |
TLSA News
- 19 days ago - Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data - GlobeNewsWire
- 21 days ago - Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million - GlobeNewsWire
- 3 months ago - Tiziana Life Sciences Appoints New Chief Executive Officer - GlobeNewsWire
- 4 months ago - Tiziana Life Sciences Granted FDA Fast Track Designation - GlobeNewsWire
- 5 months ago - Tiziana Receives $3.4 Million in Non-Dilutive Funding - GlobeNewsWire
- 5 months ago - Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer's Disease with Foralumab - GlobeNewsWire
- 6 months ago - Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research - GlobeNewsWire
- 6 months ago - Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab - GlobeNewsWire